Inventisbio Co.,Ltd.(688382),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

688382 Inventisbio Co.,Ltd.

Closed 12-12 15:00:00

31.25

+0.75

+2.46%

High31.65	Low29.17	Vol28.22M
Open30.49	D1 Closing30.50	Amplitude8.13%
Mkt Cap18.06B	Tradable Cap13.06B	Total Shares578.00M
T/O853.00M	T/O Rate6.75%	Tradable Shares418.00M
P/B10.85	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"688382","market":"SH","secType":"STK","nameCN":"Inventisbio Co.,Ltd.","latestPrice":31.25,"timestamp":1765522800000,"preClose":30.5,"halted":0,"volume":28221733,"delay":0,"changeRate":0.0246,"floatShares":418000000,"shares":578000000,"eps":-0.2011,"marketStatus":"Closed","change":0.75,"latestTime":"12-12 15:00:00","open":30.49,"high":31.65,"low":29.17,"amount":853000000,"amplitude":0.0813,"askPrice":31.27,"askSize":12,"bidPrice":31.25,"bidSize":1702,"shortable":0,"etf":0,"ttmEps":-0.2011,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":30.5,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":33.55,"lowLimit":27.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":578348491,"isCdr":false,"pbRate":10.85,"roa":"--","roe":"--","epsLYR":-0.4167,"committee":0.906955,"marketValue":18073000000,"turnoverRate":0.0676,"status":0,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-12-15.","afterMarket":{"amount":0,"volume":0,"close":31.25,"buyVolume":0,"sellVolume":0,"time":1765524839585,"indexStatus":"Closed 12-12 15:30:00","preClose":30.5},"floatMarketCap":13051000000},"requestUrl":"/m/hq/s/688382","defaultTab":"news","newsList":[{"id":"2590537333","title":"Biotech Firm InventisBio Explores Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2590537333","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590537333?lang=en_us&edition=fundamental","pubTime":"2025-12-10 08:29","pubTimestamp":1765326543,"startTime":"0","endTime":"0","summary":"InventisBio  plans to launch an initial public offering on the main board of the Hong Kong Stock Exchange, according to a Shanghai Stock Exchange filing on Wednesday.The Chinese biotech firm's board approved the plan on Monday.InventisBio said the move is aimed at enhancing its capital strength and better utilizing the diversified financing channels of the international capital market.The planned IPO is subject to approval from regulators in China and Hong Kong and the Hong Kong bourse operator.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","688382"],"gpt_icon":0},{"id":"1187926654","title":"Inventisbio Co.,Ltd. Plans to Issue H Shares and List on Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=1187926654","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187926654?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:11","pubTimestamp":1765282281,"startTime":"0","endTime":"0","summary":"On December 9, Inventisbio Co.,Ltd. (688382.SH) announced its intention to issue H shares overseas and apply for a listing on the main board of the Hong Kong Stock Exchange.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688382"],"gpt_icon":0},{"id":"2590310066","title":"Inventisbio  Says Co Plans to Seek Hong Kong Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2590310066","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590310066?lang=en_us&edition=fundamental","pubTime":"2025-12-09 19:17","pubTimestamp":1765279037,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nL4N3XF0TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["688382","BK0239"],"gpt_icon":0},{"id":"2590096310","title":"BRIEF-InventisBio Plans To Seek Hong Kong Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2590096310","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590096310?lang=en_us&edition=fundamental","pubTime":"2025-12-09 19:17","pubTimestamp":1765279037,"startTime":"0","endTime":"0","summary":"BRIEF-InventisBio Plans To Seek Hong Kong ListingDec 9 (Reuters) - InventisBio Co Ltd 688382.SS:SAYS CO PLANS TO SEEK HONG KONG LISTINGSource textFurther company coverage: 688382.SS (Reporting by Beijing Newsroom) ((Shi.Bu@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nL4N3XF0TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688382","BK0239"],"gpt_icon":0},{"id":"1168949252","title":"Top Stock Gains 223%! Social Security, Public Funds and Securities Firms Co-Held 145 Stocks in H1, Including Inventisbio Co.,Ltd. and Ningbo Zhenyu Technology Co.,Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=1168949252","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168949252?lang=en_us&edition=fundamental","pubTime":"2025-09-03 21:30","pubTimestamp":1756906235,"startTime":"0","endTime":"0","summary":"A-share listed companies have completed their 2025 semi-annual report disclosures. As important forces in the capital market, the holdings of social security funds, public funds and securities firms...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","BK0239","300953","688382"],"gpt_icon":0},{"id":"1154297216","title":"Yifan Biologics Records Five Block Trades Totaling ¥49.21 Million on July 15, Institutional Buying Dominates at ¥46.77 Million with 12.99% Discount","url":"https://stock-news.laohu8.com/highlight/detail?id=1154297216","media":"Market Watcher","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154297216?lang=en_us&edition=fundamental","pubTime":"2025-07-16 02:16","pubTimestamp":1752603370,"startTime":"0","endTime":"0","summary":"Yifan Biologics (688382.SH) surged 7.89% to close at ¥38.95 on July 15, while simultaneously registering five block trades totaling 1.452 million shares worth ¥49.2083 million. Notably, all...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688382","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-07-25","address":"上海市浦东新区中国(上海)自由贸易试验区李冰路67弄4号210室","stockEarnings":[{"period":"1week","weight":0.1129},{"period":"1month","weight":0.1882},{"period":"3month","weight":-0.1434},{"period":"6month","weight":-0.1025},{"period":"1year","weight":1.2547},{"period":"ytd","weight":1.3496}],"companyName":"益方生物科技(上海)股份有限公司","boardCode":"AI0027","perCapita":"33810股","boardName":"医药制造业","registeredCapital":"57834万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　益方生物科技(上海)股份有限公司的主营业务是创新药物的研发、生产和销售。公司的主要产品是对外授权产品贝福替尼、对外授权产品格索雷塞、临床试验阶段产品Taragarestrant、临床试验阶段产品D-0120、临床试验阶段产品D-2570。","serverTime":1765716829373,"listedPrice":18.12,"stockholders":"12352人(较上一季度增加26.17%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventisbio Co.,Ltd.(688382),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Inventisbio Co.,Ltd.(688382) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Inventisbio Co.,Ltd.,688382,Inventisbio Co.,Ltd.股票,Inventisbio Co.,Ltd.股票老虎,Inventisbio Co.,Ltd.股票老虎国际,Inventisbio Co.,Ltd.行情,Inventisbio Co.,Ltd.股票行情,Inventisbio Co.,Ltd.股价,Inventisbio Co.,Ltd.股市,Inventisbio Co.,Ltd.股票价格,Inventisbio Co.,Ltd.股票交易,Inventisbio Co.,Ltd.股票购买,Inventisbio Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventisbio Co.,Ltd.(688382),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Inventisbio Co.,Ltd.(688382) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction